A comparative study of metastatic renal cell carcinoma with correlation to subtype and primary tumor
- PMID: 11700888
- DOI: 10.1078/0344-0338-00144
A comparative study of metastatic renal cell carcinoma with correlation to subtype and primary tumor
Abstract
Clear cell (CRCC), papillary (PRCC) and chromophobe (CHRC) renal cell carcinoma (RCC) are the three most frequent subtypes of RCC. The rate and distribution of their metastatic lesions have not been well documented. We compared metastatic RCC according to subtype and primary tumor characteristics to better understand their behavior and to aid in the diagnosis of metastatic RCC. Pathology reports and clinical charts related to 283 CRCC, 48 PRCC and 13 CHRCC, including their respective sarcomatoid variants, were reviewed. A hundred and thirty-seven CRCC, 5 PRCC and 1 CHRCC with metastases were identified. CRCC and non-CRCC (PRCC and CHRCC) had different patterns of metastasis and primary tumor growth. CRCC metastases were predominantly distributed in lungs, bone, brain, lymph nodes, and adrenal glands. The associated primary CRCC measured 1.5 to 15 cm, were of all grades and stages, and were often associated with invasion of small or large veins. Three PRCC had regional lymph node metastases, 1 PRCC had both regional and mediastinal lymph node metastases. Bone metastasis was present in 1 case each of PRCC and CHRCC. One PRCC with metastasis solely to regional nodes measured 4 cm. The other 4 cases of PRCC with regional lymph node and/or distant metastases as well as the CHRCC with distant metastases were greater than 8 cm in diameter. In metastasizing and non-metastasizing non-CRCC, invasion of small veins was rare and invasion of renal veins was not seen. We cannot comment with any certainty on the metastatic behavior of CHRCC. In our experience, PRCC tend to loco-regional invasion with lymph node spread. They have a low potential for vascular invasion and distant metastases that likely occur only at late stages of the disease. CRCC has a propensity for vascular invasion and may be associated with distant metastasis at an early stage. Therefore, metastatic RCC at a distant location are most likely to be of CRCC origin than PRCC origin.
Similar articles
-
Distribution of subtypes of metastatic renal-cell carcinoma: correlating findings of fine-needle aspiration biopsy and surgical pathology.Diagn Cytopathol. 2003 Feb;28(2):66-70. doi: 10.1002/dc.10242. Diagn Cytopathol. 2003. PMID: 12561022
-
Cytohistopathologic hybrid renal cell carcinoma with papillary and clear cell features.Pathol Res Pract. 2006;202(12):863-8. doi: 10.1016/j.prp.2006.08.007. Epub 2006 Oct 10. Pathol Res Pract. 2006. PMID: 17034957
-
Analysis of clinicopathologic predictors of oncologic outcome provides insight into the natural history of surgically managed papillary renal cell carcinoma.Cancer. 2008 Apr 1;112(7):1480-8. doi: 10.1002/cncr.23322. Cancer. 2008. PMID: 18240184
-
Lymph node dissection in renal cell carcinoma.Eur Urol. 2011 Dec;60(6):1212-20. doi: 10.1016/j.eururo.2011.09.003. Epub 2011 Sep 13. Eur Urol. 2011. PMID: 21940096 Review.
-
Papillary renal cell carcinoma: radiologic-pathologic correlation and spectrum of disease.Radiographics. 2009 May-Jun;29(3):741-54; discussion 755-7. doi: 10.1148/rg.293085190. Radiographics. 2009. PMID: 19448113 Review.
Cited by
-
Combined expression of caveolin-1 and an activated AKT/mTOR pathway predicts reduced disease-free survival in clinically confined renal cell carcinoma.Br J Cancer. 2008 Mar 11;98(5):931-40. doi: 10.1038/sj.bjc.6604243. Epub 2008 Feb 19. Br J Cancer. 2008. PMID: 18283322 Free PMC article.
-
The role of surgery in clinical management of patients with metastatic papillary renal cell carcinoma.J Cancer Res Clin Oncol. 2010 Jun;136(6):905-10. doi: 10.1007/s00432-009-0732-z. Epub 2009 Dec 12. J Cancer Res Clin Oncol. 2010. PMID: 20012752 Free PMC article.
-
Sciatica leading to the discovery of a renal cell carcinoma.Pan Afr Med J. 2011;9:18. doi: 10.4314/pamj.v9i1.71193. Epub 2011 Jun 10. Pan Afr Med J. 2011. PMID: 22355428 Free PMC article. Review.
-
Phase II trial of sunitinib in patients with metastatic non-clear cell renal cell carcinoma.Invest New Drugs. 2012 Feb;30(1):335-40. doi: 10.1007/s10637-010-9491-6. Epub 2010 Aug 14. Invest New Drugs. 2012. PMID: 20711632 Free PMC article. Clinical Trial.
-
Papillary renal cell carcinoma with metastatic laparoscopic port site and vaginal involvement: a case report.J Med Case Rep. 2011 Apr 1;5:131. doi: 10.1186/1752-1947-5-131. J Med Case Rep. 2011. PMID: 21457556 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical